Literature DB >> 15271835

Intensive care management and control of infection.

Mark Ansermino1, Carolyn Hemsley.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 15271835      PMCID： PMC487741          DOI： 10.1136/bmj.329.7459.220

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  5 in total

Review 1.  Primary excision of the burn wound.

Authors:  J M Still; E J Law
Journal:  Clin Plast Surg       Date:  2000-01       Impact factor: 2.017

Review 2.  Infection of burn wounds: evaluation and management.

Authors:  S Warren; J F Burke
Journal:  Curr Clin Top Infect Dis       Date:  1991

Review 3.  Current treatment recommendations for topical burn therapy.

Authors:  W W Monafo; M A West
Journal:  Drugs       Date:  1990-09       Impact factor: 9.546

Review 4.  Burn wound infections: current status.

Authors:  B A Pruitt; A T McManus; S H Kim; C W Goodwin
Journal:  World J Surg       Date:  1998-02       Impact factor: 3.352

5.  Reduction in mortality in pediatric patients with inhalation injury with aerosolized heparin/N-acetylcystine [correction of acetylcystine] therapy.

Authors:  M H Desai; R Mlcak; J Richardson; R Nichols; D N Herndon
Journal:  J Burn Care Rehabil       Date:  1998 May-Jun
  5 in total
  11 in total

1.  Staphylococcus aureus carriage at admission predicts early-onset pneumonia after burn trauma.

Authors:  A Fournier; P Voirol; M Krähenbühl; C-L Bonnemain; C Fournier; E Dupuis-Lozeron; O Pantet; J-L Pagani; J-P Revelly; F Sadeghipour; P Eggimann; Y-A Que
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-11-04       Impact factor: 3.267

2.  Topical photodynamic treatment with poly-L-lysine-chlorin p6 conjugate improves wound healing by reducing hyperinflammatory response in Pseudomonas aeruginosa-infected wounds of mice.

Authors:  Khageswar Sahu; Mrinalini Sharma; Harsha Bansal; Alok Dube; Pradeep Kumar Gupta
Journal:  Lasers Med Sci       Date:  2012-03-28       Impact factor: 3.161

3.  Impact of Real-Time Therapeutic Drug Monitoring on the Prescription of Antibiotics in Burn Patients Requiring Admission to the Intensive Care Unit.

Authors:  P Voirol; Y-A Que; A Fournier; P Eggimann; O Pantet; J L Pagani; E Dupuis-Lozeron; A Pannatier; F Sadeghipour
Journal:  Antimicrob Agents Chemother       Date:  2018-02-23       Impact factor: 5.191

4.  Renal failure in burn patients: a review.

Authors:  S S Emara; A A Alzaylai
Journal:  Ann Burns Fire Disasters       Date:  2013-03-31

5.  Pathogen distribution and drug resistance in a burn ward: a three-year retrospective analysis of a single center in China.

Authors:  Hanghui Cen; Zhenbo Wu; Fan Wang; Chunmao Han
Journal:  Int J Clin Exp Med       Date:  2015-10-15

6.  A Retrospective Analysis of Clinical Laboratory Interferences Caused by Frequently Administered Medications in Burn Patients.

Authors:  Zachary Godwin; Kelly Lima; David Greenhalgh; Tina Palmieri; Soman Sen; Nam K Tran
Journal:  J Burn Care Res       Date:  2016 Jan-Feb       Impact factor: 1.845

7.  Arginine Is a Critical Substrate for the Pathogenesis of Pseudomonas aeruginosa in Burn Wound Infections.

Authors:  Jake Everett; Keith Turner; Qiuxian Cai; Vernita Gordon; Marvin Whiteley; Kendra Rumbaugh
Journal:  mBio       Date:  2017-03-14       Impact factor: 7.867

8.  Circular RNA expression profiles following negative pressure wound therapy in burn wounds with experimental Pseudomonas aeruginosa infection.

Authors:  Yunshu Yang; Mengdong Liu; Fangfang Yang; Xujie Wang; Xiaozhi Bai; Shengzhi Mu; Yang Liu; Dahai Hu
Journal:  Bioengineered       Date:  2022-02       Impact factor: 3.269

9.  Bloodstream infection as a predictor for mortality in severe burn patients: an 11-year study.

Authors:  D Egozi; K Hussein; S Filson; T Mashiach; Y Ullmann; A Raz-Pasteur
Journal:  Epidemiol Infect       Date:  2013-10-07       Impact factor: 4.434

10.  Lethal photosensitization of wound-associated microbes using indocyanine green and near-infrared light.

Authors:  Ghada S Omar; Michael Wilson; Sean P Nair
Journal:  BMC Microbiol       Date:  2008-07-01       Impact factor: 3.605
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.